Construction and Validation of a Robust Cancer Stem Cell-Associated Gene Set-Based Signature to Predict Early Biochemical Recurrence in Prostate Cancer
Table 1
Basic clinicopathological features of PCa patients in early BCR and long-term survival groups before and after PS matching in the discovery set.